A similar pattern of the distance effect was found for both groups (the larger the distance, the shorter the RT) and no interaction was found between the different distances and groups.
In both study groups, the largest number of hemorrhages was recorded within the first 24 hours of follow-up (Table 1).
Comparing 1-year-olds with 31- 0-year-old males clearly shows that for both age groups the largest contributing commodity was wheat, with hard > durum > soft wheat.
For both treatment groups, the largest increase in insulin dose was observed during the first few weeks of the trial, but dose continued to increase gradually throughout the trial (Supplementary Fig. 2).
Significant improvements in functional performance and health status were observed during the follow-up period in both groups, with the largest change seen in the first six weeks after the index admission (fig 5).
Significant increases occurred in both groups, but the largest increase came in the placebo group, which at one point had nearly half the group on fluid restriction versus a maximum of 27% at any point in the lixivaptan group.
In both active treatment groups, the largest mean changes were reported in BP (14.6 points and 16.5 points for etanercept 25 mg twice a week and 50 mg twice a week, respectively), SF (8.9 points and 13.8 points), RP (9.8 points and 13.1 points) and RE (10.5 points and 10.4 points) domains.
The greatest amount of P2 amplitude growth took place over the temporal-occipital area in both groups, with the largest amount of growth between Session 1 and Session 3. P2 amplitude growth was also observed at the anterior-central area and at Cz in Group 2, but was absent in Group 1.
Therefore, despite the fact that the same genes appear in both treatment groups the larger number of non-apoptosis related genes that are also activated in the co-treatment group result in a low enrichment score for the GO term apoptosis.
Although there was a similar moderate weight gain in both groups, the fructose drinkers also had larger increases in fat inside the abdomen, also associated with an increased risk of cardiovascular disease.
